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The Subacute Toxicity of l,l-Dimethylhydrazine. CORNISH, HERBERT H., 
and HARTUNG, ROLF (1969). Toxicol. Appl. Pharmacol. 15, 62-68. Daily 
injections of 70,50,30, or 10 mg UDMH/kg resulted in the death of 9,6, 5, 
and 0 rats, respectively, in each group of 10. All deaths occurred within the 
first 3 days. Animals surviving the first 3 days began to gain weight even 
though daily dosing was continued. Animals receiving more than 10 
mg/kg/day were markedly diuretic throughout the 21-day experimental 
period. Blood urea nitrogen and serum glutamic-oxaloacetic trans- 
aminase (SGOT) levels were significantly elevated in the 50 mg/kg dose 
group at 21 days. SGOT also appeared somewhat elevated in the 30 mg/kg/ 
day group. Histopathologic studies showed some evidence of early lipid 
infiltration in the tubular epithelium of the kidney. Thus, although some 
animals appear to adjust to relatively high daily doses of UDMH, bio- 
chemical and histologic evidence indicates mild kidney damage in these 
animals. 
Primarily due to the interest in unsym-dimethylhydrazine (UDMH) as a rocket fuel, 
considerable research has been undertaken to define the hazards that may be associated 
with the use of this compound (Witkin, 1956; O’Brien et al., 1964; Cornish et al., 
1965). 
Most of the data deal with the effects of a single large dose of UDMH on the experi- 
mental animal. The primary effects are tonic-clonic convulsions and death by respira- 
tory arrest. The role of vitamin Be as it relates to UDMH toxicity has also been the 
subject of numerous studies (Reeves, 1961; Geake et al., 1966). The ability of pyri- 
doxine to reverse the convulsive effects of UDMH demonstrates rather well the acute 
vitamin B6 deficiency produced by UDMH apparently through the formation of a 
UDMH-pyridoxal (or pyridoxal phosphate) hydrazone. 
Few studies have been reported concerning the effect of repeated doses of UDMH on 
experimental animals. Back and Thomas (1963) reported 21-day studies on rats at a 
daily intraperitoneal dose of 10 mg/kg/day. This daily dose was apparently without 
effect. No subacute studies have been reported using daily doses (ip or oral) greater 
than 10 mg/kg/day. Rinehart et al. (1960) reported on the subacute and chronic toxi- 
city of UDMH vapors. Animals were exposed to concentrations ranging from 50 to 
140 ppm, 6 hours a day, for up to 26 weeks. Tremors, convulsions, and death occurred 
at high exposure levels. Dogs exposed to 5 ppm of UDMH for 26 weeks showed slight 
hemolytic anemia and bilirubinemia. 
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The present study was designed to measure the effect of repeated daily doses of 
UDMH on rats. Dosage levels ranged from 10 to 70 mg/kg/day given by ip injection. 
METHODS 
Female rats of the Sprague-Dawley strain were utilized in this study. Animals were 
given food and water ad libitum. 
Groups of 10 female rats weighing approximately 225 g each were given daily ip 
injections of 70, 50, 30, or 10 mg/kg of UDMH for a period of 3 weeks. The solution 
injected was a constant concentration of 25 mg/ml. A fifth group received a compar- 
able volume of 0.9 % NaCl. The 10 mg/kg treatment group was given 18 injections; all 
other groups received 21. The belly of each rat was shaved at the beginning of the 
study, disinfectant (Bactine) was applied before each injection, and a sterile needle 
was used for each rat. The injection site was alternated daily from side to side. The 
UDMH solution of 25 mg/ml was made up immediately before use. 
Seven animals from each group were kept in individual metabolism cages for 
measurement of urine excretion. Water bottles were checked carefully to prevent 
dilution of urine samples. Daily body weight and urine excretion were recorded. 
At the end of the study period, surviving rats were sacrificed, organ weights were 
determined, and tissue samples from 2 rats in each group were taken for histopatho- 
logic evaluation. White blood cell counts, hemoglobin, hematocrit, blood urea 
nitrogen, and serum glutamic-oxaloacetic transaminase (SGOT) levels were deter- 
mined on all animals. One unit is equivalent to an optical density change of 0.001. 
Data are reported as the mean f one standard error. 
RESULTS 
Mortality data from this study are shown in Table 1. All animals survived a dose of 
10 mg/kg of UDMH per day for a 3-week period. Half of the animals (5) survived at 
the 30 mg/kg dose, 4 survived the 50 mg/kg level, and 1 survived the 70 mg/kg dose. 
All deaths occurred within the first 3 days. After this time, all animals survived even 
though daily dosing continued for 3 weeks. 
Body weight losses (Fig. 1) of surviving animals were also largely restricted to the 
first few days after the beginning of dosing and occurred in animals at all dosage levels. 
TABLE 1 
MORTALITY OF RATS GIVEN DAILY INTRAPERITONEAL 
INJECTIONS OF UDMH 
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Even the control group injected with saline exhibited a slight weight loss during the 
first few days. Animals receiving IO-30 mg/kg/day of UDMH resumed their normal 
growth pattern rather promptly, while those receiving 50 mg/kg/day, although con- 
tinuing to gain weight, had a more erratic course and remained considerably below 
the average weight of the other groups for several weeks. The 1 surviving rat receiving 
70 mg/kg/day gained weight slowly and was still below its original weight at time of 
sacrifice. 
The average daily urine output of the group of rats given 10 mg/kg/day was the 
same as the control group (Fig. 2). Daily injections of 30-50 mg/kg/day resulted in 
marked and sustained diuresis throughout the 3-week period. Total urine output for 
this period is included in Table 2, the volume in the two high-dose groups being more 
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FIG. 1. Growth rates of rats receiving daily intraperitoneal injections of UDMH, mean f I standard 
error. 
A summary of the data obtained in a number of other studies conducted on these 
animals at the termination of the injection schedule is shown in Table 2. Mean white 
blood cell counts, hemoglobin, and hematocrit values were not affected by the 10, 30, 
and 50 mg/kg daily dose of UDMH over the 3-week period. The single rat surviving 
the 70 mg/kg daily dose was apparently near death and had a white cell count of only 
1800. Three of the 4 surviving rats given 50 mg/kg/day had elevated blood urea nitro- 
gen levels suggestive of early kidney damage. 
SGOT levels showed an increasing elevation with increasing dosage levels. The single 
surviving member of the group receiving 70 mg/kg/day had an SGOT level of 124 
units compared with control levels averaging 47.2 f 2.0 units. 
Organ to body weight ratios expressed as percent of body weight, for heart, liver, 
kidney, spleen, and lung of these animals are shown in Table 3. None of these values 
are significantly different from the control groups. 
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Histopathologic findings in these animals were slight. In the one surviving animal 
receiving 70 mg/kg/day, the liver showed slight lipid infiltration, but similar findings 
were present in a number of control animals. The kidney, however, showed swelling 
of the tubular epithelial cells, and multiple fat droplets, with large droplets in the 
renal tubules and an occasional small droplet in a glomerular capillary. Some of the 
50 mg/kg/day group also showed early fatty changes in the tubular epithelium of the 
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FIG. 2. Daily urine volumes of rats receiving daily intraperitoneal injections of UDMH, mean +l 
standard error. 
DISCUSSION 
Repeated injections of 70, 50, or 30 mg/kg/day of UDMH resulted in a high rat 
mortality rate. On the 70 mg/kg/day dose, 9 of 10 rats died during the first 2 days. On 
the 50 mg/kg/day level, 6 rats died during days 2 and 3. On the 30 mg/kg/day dose, 
5 of 10 rats died during days 2 and 3. Four of these deaths occurred on day 3. Deaths 
occurring on the second and third day of dosing suggest that there is accumulative or 
delayed effect of UDMH. However, all animals that survived the first 3 days of dosing 
survived for the total 3-week period. Animals on the 10 mg/kg per day dose and the 
saline controls all survived the 21-day treatment period. The essentially no effect level 
of 10 mg/kg day is consistent with the studies of Back and Thomas (1963), who found 
no effect after 20 days of ip injections at this level. Animals surviving the initial doses 
all gained weight at approximately the same rate. The initial weight loss in these ani- 
mals was proportional to the dose of UDMH, being greatest at the high levels. At the 





































































































































































































































































































































































































































































































































































































































TOXICITY OF UDMH 67 
weights comparable to the controls. Animals receiving 50 mg/kg/day were approxi- 
mately 10 g below the weight of control rats at the end of 3 weeks. 
There is little evidence of an effect on the hematopoietic system since white blood 
cell count, hemoglobin, and hematocrit values of all animals in the 10, 30, and 50 
mg/kg/day groups were comparable to controls, although white counts became more 
variable with increasing dosage. The white cell count in the single surviving animal in 
the 70 mg/kg/day group was markedly depressed and the animal near death. This is 
somewhat in contrast to the report of Rinehart et al. (1960), who found definite anemia 
in dogs exposed to UDMH. They also noted, however, that dogs were significantly 
more sensitive to UDMH than were rats. In addition, the vapor exposure studies on 
dogs were continued for 13-26 weeks. It is also interesting to note that sustained 
diuresis in these animals did not result in hemoconcentration. 
Earlier studies have shown that a single dose of UDMH produced a rather marked 
diuresis in rats (Barth et al., 1967). Not only was an immediate diuresis noted in the 
present study with doses of 30 mg/kg, or greater, but diuresis continued over the entire 
3-week period of injection. Total urine output over this period was more than twice 
that of normal rats. Thus, there was no readjustment of excretion rate when UDMH 
was injected on a daily basis over a 21-day period. It is difficult to determine whether 
the diuretic effect was dose dependent, although after the first week, the urine output 
of the 50 mg/kg/day dose group remained consistently above that of the 30 mg/kg/day 
group for the remaining 2 weeks. Although the mechanism of this diuretic action is 
not clear, previous studies have shown that this is primarily a water diuresis (Barth 
et al., 1967). 
The elevation of blood urea nitrogen levels in animals on the high dose is suggestive 
of early kidney damage. Tissue pathologic changes would tend to support this finding 
since there was cloudy swelling and lipid infiltration in the renal tubules in the 50 and 
70 mg/kg/day groups. 
The elevation of SGOT is more difficult to interpret. What appears to be a gradual 
increase in SGOT in the various groups is not due to diuresis and hemoconcentration, 
since hematocrit values remain constant in all groups. Whether this is an indication of 
early liver or kidney damage is not apparent. Although the livers of some treated 
animals showed early degenerative fatty infiltration, similar findings occur in some 
control animals. The report by Reinhardt and Dinman (1965) demonstrated an ele- 
vated level of rat serum lactic dehydrogenase 16 hours after a single ip injection of 
80 mg of UDMH per kilogram of body weight. No histologic evidence of liver damage 
was found in those studies. The SGOT increase found in the present studies is not great 
and could conceivably be related to the incipient kidney damage which is found in the 
histopathologic studies of the high-dose groups. That mean SGOT levels start to rise, 
even in the lower dosage groups, is suggestive of an early tissue effect which may not 
be evident in histopathologic studies. 
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